Investor's Business Daily on MSN
Biogen is celebrating a first in Alzheimer's disease, but investors are leery
Biogen unveiled mixed results Thursday for its tau-targeting Alzheimer's treatment, leading the stock to drop.
This post was co-authored by Erin Marshall. In life, it can be easy to get caught up in the pursuit of success. We have been conditioned to believe that we need to be faster, smarter, richer, better, ...
WA School of Mines: Minerals, Energy and Chemical Engineering, Curtin University, Perth, WA6102, Australia Article Views are the COUNTER-compliant sum of full text article downloads since November ...
From “play-cations” to under-the-radar destinations, here are this season’s hottest travel trends, according to a new report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results